- Home
- QTRX vs LYEL Comparison
QTRX vs LYEL Comparison
Compare QTRX & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTRX
- LYEL
- Stock Information
- Founded
- QTRX 2007
- LYEL 2018
- Country
- QTRX United States
- LYEL United States
- Employees
- QTRX N/A
- LYEL N/A
- Industry
- QTRX Biotechnology: Laboratory Analytical Instruments
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- QTRX Industrials
- LYEL Health Care
- Exchange
- QTRX Nasdaq
- LYEL Nasdaq
- Market Cap
- QTRX 223.6M
- LYEL 207.7M
- IPO Year
- QTRX 2017
- LYEL 2021
- Fundamental
- Price
- QTRX $5.41
- LYEL $0.41
- Analyst Decision
- QTRX Buy
- LYEL Sell
- Analyst Count
- QTRX 5
- LYEL 2
- Target Price
- QTRX $16.20
- LYEL $1.00
- AVG Volume (30 Days)
- QTRX 640.4K
- LYEL 632.8K
- Earning Date
- QTRX 05-12-2025
- LYEL 05-20-2025
- Dividend Yield
- QTRX N/A
- LYEL N/A
- EPS Growth
- QTRX N/A
- LYEL N/A
- EPS
- QTRX N/A
- LYEL N/A
- Revenue
- QTRX $137,421,000.00
- LYEL $61,000.00
- Revenue This Year
- QTRX $5.22
- LYEL N/A
- Revenue Next Year
- QTRX $15.31
- LYEL N/A
- P/E Ratio
- QTRX N/A
- LYEL N/A
- Revenue Growth
- QTRX 12.30
- LYEL N/A
- 52 Week Low
- QTRX $4.67
- LYEL $0.39
- 52 Week High
- QTRX $19.18
- LYEL $2.88
- Technical
- Relative Strength Index (RSI)
- QTRX 44.83
- LYEL 39.36
- Support Level
- QTRX $5.21
- LYEL $0.40
- Resistance Level
- QTRX $5.75
- LYEL $0.51
- Average True Range (ATR)
- QTRX 0.39
- LYEL 0.04
- MACD
- QTRX 0.05
- LYEL 0.00
- Stochastic Oscillator
- QTRX 35.71
- LYEL 14.35
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.